Human Antibodies
SJR0.363
GB
GBJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.363 | Q3 | 49.9% | |
| 2024 | — | — | 0.499 | Q3 | 62.1% | |
| 2023 | — | — | 0.365 | Q3 | 54.8% | |
| 2022 | — | — | 0.333 | Q3 | 53.8% | |
| 2021 | — | — | 0.235 | Q4 | 44.0% | |
| 2020 | — | — | 0.274 | Q3 | 47.4% | |
| 2019 | — | — | 0.312 | Q3 | 53.6% | |
| 2018 | — | — | 0.395 | Q3 | 58.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1875-869X
ISSN
1093-2607
country
GBcoverage
1990-1997, 1999-2013, 2015-2025